Results 201 to 210 of about 81,901 (217)

TRIPS, pharmaceutical patents, and generic competition in India. [PDF]

Health Aff Sch
Kyle MK, Sampat BN, Shadlen KC.
europepmc   +1 more source

Computed Tomography Imaging and Characteristics of In Situ Forming Implants with Different PLGA Endcaps

Chemical & Biomedical Imaging
Xinhao Lin, Zixuan Zhen, Seyyed Majid Eslami, Nour Al Zouabi, Lauren Elizabeth Ward, Mittal Darji, Sheyda Ranjbar, Francis K. Masese, André O’Reilly Beringhs, Rajeswari M. Kasi, Qiangnan Zhang, Qi Li, Qin Bin, Yan Wang, Hong Yuan, Xiuling Lu   +15 more
doaj   +1 more source

Priced Out of Treatment: The Exorbitant Cost of Antiparasitic Drugs in the United States. [PDF]

Open Forum Infect Dis
Alperin C, Nguyen N, Duffey M, Clark EH.
europepmc   +1 more source

Purdue's development of abuse-deterrent formulation opioids as a response to market competition: An industry documents analysis. [PDF]

SSM Qual Res Health
DiMario A, Knight K, Schmidt LA, Apollonio DE.   +3 more
europepmc   +1 more source

Impact of a local formulary on prescribing patterns and pharmaceutical expenditure: an observational study in Japan. [PDF]

J Pharm Health Care Sci
Koike H, Taguchi M, Koide A, Yamada H.
europepmc   +1 more source

Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis.

JAMA Health Forum
Li P, Klebanoff MJ, Lin JK, Doshi KD, Chahin S, Doshi JA.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Children expect generic knowledge to be widely shared

Cognition, 2012
Andrei Cimpian, Rose M Scott
exaly  

Are there potential problems with generic substitution of antiepileptic drugs?

Seizure: the Journal of the British Epilepsy Association, 2006
M Feely, P Crawford
exaly  

Relationship between generic strategies, competitive advantage and organizational performance: an empirical analysis

Technovation, 1999
Felix Mavondo, A Gunasekaran
exaly